Results 41 to 50 of about 10,024,591 (280)
Predicting major adverse limb events in individuals with type 2 diabetes: Insights from the EXSCEL trial [PDF]
Aims: Although models exist to predict amputation among people with type 2 diabetes with foot ulceration or infection, we aimed to develop a prediction model for a broader range of major adverse limb events (MALE)—including gangrene, revascularization ...
Buse J.B +13 more
core +2 more sources
Cardiovascular complications after lower extremity revascularization (LER) are common in diabetic patients with peripheral arterial disease (PAD) and chronic limb threatening ischemia (CLTI).
Federico Biscetti +12 more
doaj +1 more source
Background Cardiovascular complications represent the major cause of morbidity and mortality of type 2 diabetes mellitus (T2DM) patients. In particular, peripheral artery disease (PAD) represents a frequent T2DM vascular complication and a risk factor ...
Federico Biscetti +11 more
doaj +1 more source
Angiogenesis-related proteins as biomarkers for peripheral artery disease
Background: Angiogenesis plays an important role in peripheral artery disease (PAD) and angiogenesis-related proteins may act as prognostic biomarkers.
Ben Li +6 more
doaj +1 more source
© 2019, Springer Healthcare Ltd., part of Springer Nature. Introduction: Collectively, coronary artery disease (CAD) and peripheral artery disease (PAD) are highly prevalent and are associated with increased risk of major adverse cardiovascular events ...
Zhao, Qi +7 more
core +1 more source
Background Patients with peripheral artery disease are at increased risk for major adverse cardiac events, major adverse limb events, and all‐cause death.
Robert D. McBane +14 more
doaj +1 more source
Chapter 1 introduces what is known about the current challenges of medication management in the elderly, with a special focus on management of potentially inappropriate medications (PIMs) in clinical practice.
Aguiar, João Pedro
core +1 more source
Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan
ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Kayoko Saito +8 more
wiley +1 more source
Background: : Patient, lesion, and procedural characteristics may impact the long-term risks of adverse limb outcomes differently after successful endovascular revascularization for lower extremity peripheral artery disease.
Edwin Mandieka, MD +5 more
doaj +1 more source
Peripheral artery disease (PAD) is a severe manifestation of atherosclerosis. Patients with PAD are at heightened risk for atherothrombotic complications, including myocardial infarction and stroke (MACE); however, there is also an equal or greater risk ...
Justin T. Morrison MD +3 more
doaj +1 more source

